Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 2500
Single User License Price INR 181375
Corporate User License Price USD 7500
Corporate User License Price INR 544125
Site License Price USD 5000
Site License Price INR 362750
Request a Quote

Report Title

Histoplasmosis Global Clinical Trials Review, H2, 2016

Quote Request for License Type
License Type Price  
Single User License USD 2500
Site License USD 5000
Enterprise Wide License USD 7500
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Histoplasmosis Global Clinical Trials Review, H2, 2016


Quote Request for License Type
License Type Price  
Single User License USD 2500
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Histoplasmosis Global Clinical Trials Review, H2, 2016

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Histoplasmosis Global Clinical Trials Review, H2, 2016



Executive Summary

Histoplasmosis Global Clinical Trials Review, H2, 2016

Summary

GlobalData's clinical trial report, "Histoplasmosis Global Clinical Trials Review, H2, 2016" provides an overview of Histoplasmosis clinical trials scenario. This report provides top line data relating to the clinical trials on Histoplasmosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Report Guidance 4

Clinical Trials by Region 5

Clinical Trials and Average Enrollment by Country 6

Top Countries Contributing to Clinical Trials in Asia-Pacific 8

Top Countries Contributing to Clinical Trials in North America 9

Clinical Trials by G7 Countries: Proportion of Histoplasmosis to Infectious Disease Clinical Trials 10

Clinical Trials in G7 Countries by Trial Status 11

Clinical Trials by Phase 12

Clinical Trials by Trial Status 13

Clinical Trials by End Point Status 14

Clinical Trials by Sponsor Type 15

Prominent Sponsors 16

Top Companies Participating in Histoplasmosis Therapeutics Clinical Trials 17

Prominent Drugs 18

Clinical Trial Profile Snapshots 19

Appendix 26

Abbreviations 26

Definitions 26

Research Methodology 27

Secondary Research 27

About GlobalData 28

Contact Us 28

Disclaimer 28

Source 29

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Histoplasmosis Therapeutics, Global, Clinical Trials by Region (%), 2016* 5

Histoplasmosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6

Histoplasmosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7

Proportion of Histoplasmosis to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 10

Histoplasmosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 11

Histoplasmosis Therapeutics, Global, Clinical Trials by Phase (%), 2016* 12

Histoplasmosis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 13

Histoplasmosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 15

Histoplasmosis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 16

Histoplasmosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 17

Histoplasmosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 18

GlobalData Methodology 27

List of Tables

Histoplasmosis Therapeutics, Global, Clinical Trials by Region, 2016* 5

Histoplasmosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6

Histoplasmosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7

Histoplasmosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 8

Histoplasmosis Therapeutics Clinical Trials, North America, Top Countries, 2016* 9

Proportion of Histoplasmosis to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 10

Histoplasmosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 11

Histoplasmosis Therapeutics, Global, Clinical Trials by Phase, 2016* 12

Histoplasmosis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 13

Histoplasmosis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 14

Histoplasmosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 15

Histoplasmosis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 16

Histoplasmosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 17

Histoplasmosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 18

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Johnson & Johnson

F. Hoffmann-La Roche Ltd.

Novartis AG

Medionics International Inc

Chemo Espana, S.A.

Histoplasmosis Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Histoplasmosis, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand